LoadingFMBM
Truban Erica N. reported 102 shares of Common Stock in F&M BANK CORP as grants or awards dated 2026-09-24. The Form 4 was disclosed on Sep 28, 2026. These were stock awards, not open-market purchases.
ASND
BIENAIME JEAN JACQUES reported Disposition to issuer in Ascendis Pharma A/S: 9160 units of Warrants (derivative), dated 2026-04-14. The full Form 4 contains 2 transaction entries.
DELL
DORMAN DAVID W reported 633 shares of Class C Common Stock in Dell Technologies Inc. as grants or awards dated 2026-09-24. The Form 4 was disclosed on Sep 28, 2026. These were stock awards, not open-market purchases.
P
Singh Ajay reported Sale in Everpure, Inc.: 42930 units of Class A Common Stock, dated 2026-09-24. The full Form 4 contains 1 transaction entry.
DELL
GRAIN DAVID J reported 633 shares of Class C Common Stock in Dell Technologies Inc. as grants or awards dated 2026-09-24. The Form 4 was disclosed on Sep 28, 2026. These were stock awards, not open-market purchases.
CDW
Sanderson Katherine Elizabeth reported Tax/exercise withholding in CDW Corp: 231.81 units of Common Stock, par value $0.01, dated 2026-09-24. The full Form 4 contains 1 transaction entry.
LEGN
Sanders Corazon (Corsee) D. reported Grant or award in Legend Biotech Corp: 20986 units of Ordinary Shares, dated 2026-09-24. The full Form 4 contains 1 transaction entry.
LEGN
Ji Darren Xiaohui reported Grant or award in Legend Biotech Corp: 28330 units of Ordinary Shares, dated 2026-09-24. The full Form 4 contains 1 transaction entry.
LEGN
Casey Patrick John reported Grant or award in Legend Biotech Corp: 20986 units of Ordinary Shares, dated 2026-09-24. The full Form 4 contains 1 transaction entry.
LEGN
Mao Li reported Grant or award in Legend Biotech Corp: 20986 units of Ordinary Shares, dated 2026-09-24. The full Form 4 contains 1 transaction entry.
LEGN
Heyman Tomas J. reported Grant or award in Legend Biotech Corp: 20986 units of Ordinary Shares, dated 2026-09-24. The full Form 4 contains 1 transaction entry.
LEGN
Salovey Peter reported Grant or award in Legend Biotech Corp: 28330 units of Ordinary Shares, dated 2026-09-24. The full Form 4 contains 1 transaction entry.
CDRO
Iglesias Sanchez Oscar reported Sale in Codere Online Luxembourg, S.A.: 460 units of Ordinary Shares, dated 2026-09-25. The full Form 4 contains 1 transaction entry.
AYI
Tzitzon Nicholas reported Grant or award in ACUITY INC. (DE): 296 units of Deferred Restricted Stock Units (derivative), dated 2026-09-24. The full Form 4 contains 1 transaction entry.
DELL
GREEN WILLIAM D reported 680 shares of Class C Common Stock in Dell Technologies Inc. as grants or awards dated 2026-09-24. The Form 4 was disclosed on Sep 28, 2026. These were stock awards, not open-market purchases.
AMC
ELLIS DANIEL E reported Grant or award in AMC ENTERTAINMENT HOLDINGS, INC.: 402577 units of RESTRICTED STOCK UNITS (derivative), dated 2026-09-24. The full Form 4 contains 1 transaction entry.
FMBM
Willingham John A. reported 69 shares of Common Stock in F&M BANK CORP as grants or awards dated 2026-09-24. The Form 4 was disclosed on Sep 28, 2026. These were stock awards, not open-market purchases.
FMBM
WRAY PETER H reported 153 shares of Common Stock in F&M BANK CORP as grants or awards dated 2026-09-24. The Form 4 was disclosed on Sep 28, 2026. These were stock awards, not open-market purchases.
AMC
Goodman Sean D. reported Grant or award in AMC ENTERTAINMENT HOLDINGS, INC.: 708535 units of RESTRICTED STOCK UNITS (derivative), dated 2026-09-24. The full Form 4 contains 1 transaction entry.
FMBM
Keeler Anne B reported 153 shares of Common Stock in F&M BANK CORP as grants or awards dated 2026-09-24. The Form 4 was disclosed on Sep 28, 2026. These were stock awards, not open-market purchases.
AMC
CHAVARRIA CARLA C reported Grant or award in AMC ENTERTAINMENT HOLDINGS, INC.: 322062 units of RESTRICTED STOCK UNITS (derivative), dated 2026-09-24. The full Form 4 contains 1 transaction entry.
FMBM
Houff Neil A. reported 153 shares of Common Stock in F&M BANK CORP as grants or awards dated 2026-09-24. The Form 4 was disclosed on Sep 28, 2026. These were stock awards, not open-market purchases.
TBPH
Weiss Asset Management LP; WEISS ANDREW M; WAM GP LLC reported Other (see filing) in Theravance Biopharma, Inc.: 7457060 units of Ordinary Share $0.00001 Par Value, dated 2026-09-23. The full Form 4 contains 1 transaction entry.
FMBM
Hutman Hannah W. reported 153 shares of Common Stock in F&M BANK CORP as grants or awards dated 2026-09-24. The Form 4 was disclosed on Sep 28, 2026. These were stock awards, not open-market purchases.
